Liu, Yanfei
Ping, Lingyan
Song, Yuqin
Tang, Yongjing
Zheng, Wen
Liu, Weiping
Ying, Zhitao
Zhang, Chen
Wu, Meng
Feng, Feier
Lin, Ningjing
Tu, Meifeng
Zhu, Jun
Xie, Yan
Article History
Received: 10 October 2023
Accepted: 28 February 2024
First Online: 7 March 2024
Declarations
:
: The study secured approval from Ethics Committee of Peking University Cancer Hospital and Institute (No. 2019YJZ68) and was executed in alignment with the Declaration of Helsinki and Good Clinical Practice guidelines. All participants provided informed consent. The trial is registered at ClinicalTrials.gov under the identifier NCT04239170.
: Not applicable.
: None declared.